Does HIV Infection Promote Early Kidney Injury in Women?

Szczech L.A. , Gange S.J. , van der Horst C. Predictors of proteinuria and renal failure among women with HIV infection. Kidney Int 2002; 61: 195–202.

Szczech L.A. , Hoover D.R. , Feldman J.G. Association between renal disease and outcomes among HIV-infected women receiving or not receiving antiretroviral therapy. Clin Infect Dis 2004; 39: 1199–1206.

Krawczyk C.S. , Holmberg S.D. , Moorman A.C. , Gardner L.I. , McGwin G.J. Factors associated with chronic renal failure in HIV-infected ambulatory patients. AIDS 2004; 18: 2171–2178.

Gupta S.K. , Mamlin B.W. , Johnson C.S. , Dollins M.D. , Topf J.M. , Dube M P. Prevalence of proteinuria and the development of chronic kidney disease in HIV-infected patients. Clin Nephrol 2004; 61: 1–6.

Gardner L.I. , Holmberg S.D. , Williamson J.M. Development of proteinuria or elevated serum creatinine and mortality in HIV-infected women. J Acquir Immune Defic Syndr 2003; 32: 203–209.

Eggers P.W. , Kimmel P.L. Is there an epidemic of HIV infection in the US ESRD program? J Am Soc Nephrol 2004; 15: 2477–2485.

Odden M.C. , Scherzer R. , Bacchetti P. Cystatin C level as a marker of kidney function in human immunodeficiency virus infection: the FRAM study. Arch Intern Med 2007; 167: 2213–2219.

Szczech L.A. , Grunfeld G. , Scherzer R. Microalbuminuria in HIV infection. AIDS 2007; 21: 1003–1009.

Choi A. , Scherzer R. , Bacchetti P. Cystatin C, albuminuria, and 5-year all-cause mortality in HIV-infected persons. Am J Kidney Dis 2010; 56: 872–882.

Driver T.H. , Scherzer R. , Peralta C.A. Comparisons of creatinine and cystatin C for detection of kidney disease and prediction of all-cause mortality in HIV-infected women. AIDS 2013; 27: 2291–2299.

Wools-Kaloustian K. , Gupta S.K. , Muloma E. Renal disease in an antiretroviral-naive HIV-infected outpatient population in Western Kenya. Nephrol Dial Transplant 2007; 22: 2208–2212.

Cheung C.Y. , Wong K.M. , Lee M.P. Prevalence of chronic kidney disease in Chinese HIV-infected patients. Nephrol Dial Transplant 2007; 22: 3186–3190.

Wyatt C.M. , Morgello S. , Katz-Malamed R. The spectrum of kidney disease in patients with AIDS in the era of antiretroviral therapy. Kidney Int 2009; 75: 428–434.

Wyatt C.M. , Winston J.A. , Malvestutto C.D. Chronic kidney disease in HIV infection: an urban epidemic. AIDS 2007; 21: 2101–2103.

Astor B.C. , Kottgen A. , Hwang S.J. , Bhavsar N. , Fox C.S. , Coresh J. Trefoil factor 3 predicts incident chronic kidney disease: a case-control study nested within the Atherosclerosis Risk in Communities (ARIC) Study. Am J Nephrol 2011; 34: 291–297.

O'Seaghdha C.M. , Hwang S.J. , Bhavsar N.A. Lower urinary connective tissue growth factor levels and incident CKD stage 3 in the general population. Am J Kidney Dis 2011; 57: 841–849.

Shlipak M.G. , Scherzer R. , Abraham A. Urinary markers of kidney injury and kidney function decline in HIV-infected women: biomarkers and kidney decline. J Acquir Immune Defic Syndr 2012; 61: 565–573.

Peralta C.A. , Scherzer R. , Grunfeld C. Urinary biomarkers of kidney injury are associated with all-cause mortality in the Women's Interagency HIV Study. HIV Med 2012; doi: 10.1111/hiv.12113.

Barkan S.E. , Melnick S.L. , Preston-Martin S. The Women's Interagency HIV Study. WIHS Collaborative Study Group. Epidemiology 1998; 9: 117–125.

Chaturvedi S. , Farmer T. , Kapke G.F. Assay validation for KIM-1: human urinary renal dysfunction biomarker. Int J Biol Sci 2009; 5: 128–134.

Bennett M. , Dent C.L. , Ma Q. Urine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective study. Clin J Am Soc Nephrol 2008; 3: 665–673.

Gilks W.R. , Richardson S. , Spiegehalter D.J. Markov chain Monte Carlo in practice. London: Chapman & Hall 1996.

Levey A.S. , Stevens L.A. , Schmid C.H. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604–612.

Inker L.A. , Eckfeldt J. , Levey A.S. Expressing the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) cystatin C equations for estimating GFR with standardized serum cystatin C values. Am J Kidney Dis 2011; 58: 682–684.

Huber P. The behavior of maximum likelihood estimates under nonstandard conditions. Proceedings of the Fifth Berkeley Symposium on Mathematical Statistics and Probability 1967; 1: 221–233.

White H. A heteroskedasticity-consistent covariance matrix estimator and a direct test for heteroskedasticity. Econometrica 1980; 48: 817–830.

Lumley T. , Kronmal R. , Ma S. Relative risk regression in medical research: models, contrasts, estimators, and algorithms. UW Biostatistics Working Paper Series 2006: working paper 293. (Updated 19 July 2006. Accessed 17 October 2013.) Available from http://biostats.bepress.com/uwbiostat/paper293.

Hoeting J.M.D. , Raftery A. , Volinsky C. Bayesian model averaging: a tutorial. Stat Sci 1999; 14: 382–401.

Parikh C.R. , Jani A. , Melnikov V.Y. , Faubel S. , Edelstein C.L. Urinary interleukin-18 is a marker of human acute tubular necrosis. Am J Kidney Dis 2004; 43: 405–414.

Ichimura T. , Bonventre J.V. , Bailly V. Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J Biol Chem 1998; 273: 4135–4142.

Ichimura T. , Hung C.C. , Yang S.A. , Stevens J.L. , Bonventre J.V. Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury. Am J Physiol Renal Physiol 2004; 286: F552–F563.

Han W.K. , Bailly V. , Abichandani R. , Thadhani R. , Bonventre J V. Kidney injury molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int 2002; 62: 237–244.

Parikh C.R. , Mishra J. , Thiessen-Philbrook H. Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery. Kidney Int 2006; 70: 199–203.

Parikh C.R. , Abraham E. , Ancukiewicz M. , Edelstein C.L. Urine IL-18 is an early diagnostic marker for acute kidney injury and predicts mortality in the intensive care unit. J Am Soc Nephrol 2005; 16: 3046–3052.

Kilis-Pstrusinska K. , Medynska A. , Zwolinska D. , Wawro A. Interleukin-18 in urine and serum of children with idiopathic nephrotic syndrome. Kidney Blood Press Res 2008; 31: 122–126.

Matsumoto K. , Kanmatsuse K. Elevated interleukin-18 levels in the urine of nephrotic patients. Nephron 2001; 88: 334–339.

Nepal M. , Bock G.H. , Sehic A.M. , Schultz M.F. , Zhang P.L. Kidney injury molecule-1 expression identifies proximal tubular injury in urate nephropathy. Ann Clin Lab Sci 2008; 38: 210–214.

van Timmerren M.M. , ven den Heuvel M.C. , Bailly V. , Bakker S.J. , van Goor H. , Stegeman C.A. Tubular kidney injury molecule-1 (KIM-1) in human renal disease. J Pathol 2007; 212: 209–217.

Mishra J. , Dent C. , Tarabishi R. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 2005; 365: 1231–1238.

Parikh C.R. , Jani A. , Mishra J. Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation. Am J Transplant 2006; 6: 1639–1645.

Nickolas T.L. , O'Rourke M.J. , Yang J. Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury. Ann Intern Med 2008; 148: 810–819.

Bolignano D. , Coppolino G. , Campo S. Neutrophil gelatinase-associated lipocalin in patients with autosomal-dominant polycystic kidney disease. Am J Nephrol 2007; 27: 373–378.

Ding H. , He Y. , Li K. Urinary neutrophil gelatinase-associated lipocalin (NGAL) is an early biomarker for renal tubulointerstitial injury in IgA nephropathy. Clin Immunol 2007; 123: 227–234.

Brunner H.I. , Mueller M. , Rutherford C. Urinary neutrophil gelatinase-associated lipocalin as a biomarker of nephritis in childhood-onset systemic lupus erythematosus. Arthritis Rheum 2006; 54: 2577–2584.

Ross M.J. , Klotman P.E. Recent progress in HIV-associated nephropathy. J Am Soc Nephrol 2002; 13: 2997–3004.

Bruggeman L.A. , Ross M.D. , Tanji N. Renal epithelium is a previously unrecognized site of HIV-1 infection. J Am Soc Nephrol 2000; 11: 2079–2087.

Winston J.A. , Bruggeman L.A. , Ross M.D. Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection. N Engl J Med 2001; 344: 1979–1984.

Sola-Del Valle D.A. , Mohan S. , Cheng J.T. Urinary NGAL is a useful clinical biomarker of HIV-associated nephropathy. Nephrol Dial Transplant 2011; 26: 2387–2390.

Choi A.I. , Rodriguez R.A. , Bacchetti P. , Bertenthal D. , Volberding P.A. , O'Hare A.M. The impact of HIV on chronic kidney disease outcomes. Kidney Int 2007; 72: 1380–1387.

Lucas G.M. , Lau B. , Atta M.G. , Fine D.M. , Keruly J. , Moore R.D. Chronic kidney disease incidence, and progression to end-stage renal disease, in HIV-infected individuals: a tale of two races. J Infect Dis 2008; 197: 1548–1557.

Jotwani V. , Li Y. , Grunfeld C. , Choi A.I. , Shlipak M. Risk factors for end-stage renal disease in HIV-infected individuals: traditional and HIV-related factors. AJKD 2012; 59: 628–635.

Rosset S. , Tzur S. , Behar D.M. , Wasser W.G. , Skorecki K. The population genetics of chronic kidney disease: insights from the MYH9-APOL1 locus. Nat Rev Nephrol 2011; 7: 313–326.